Warning: Creating default object from empty value in /home/customer/www/americanhealthcouncil.org/public_html/wp-content/themes/enfold/config-templatebuilder/avia-shortcodes/slideshow_layerslider/slideshow_layerslider.php on line 28

Warning: session_start(): Cannot start session when headers already sent in /home/customer/www/americanhealthcouncil.org/public_html/wp-content/themes/enfold/config-templatebuilder/avia-shortcodes/masonry_entries/masonry_entries.php on line 56
FDA Approved Drug 'Tecentriq' to Treat Bladder Cancer | American Health Council

FDA Approved Drug ‘Tecentriq’ to Treat Bladder Cancer

FDA Approved Drug 'Tecentriq' to Treat Bladder Cancer - Health Council

There’s a new drug approved by the FDA for bladder cancer:

“Tecentriq (atezolizumab) treats the most common type of bladder cancer, called urothelial carcinoma. It’s the first in its class of drugs, called PD-1/PD-L1 inhibitors, approved to treat this type of cancer.”

Read the full article: FDA Approves New Drug to Treat Bladder Cancer